Pages that link to "Template:DocumentData"

The following pages link to Template:DocumentData:

Displaying 50 items.

• Document:FRA SI RIPH 2G - Website 16-May-2025 (transclusion) (← links)
• Document:FRA SURV VIG DOC118 V01 REC-Avis aux promoteurs -Partie V 16-May-2025 (transclusion) (← links)
• Document:GBR Clinical investigations of medical devices – compiling a submission to MHRA May 2021 (transclusion) (← links)
• Document:GBR Clinical Trial toolkit 28-Jan-2025 (transclusion) (← links)
• Document:GBR Data Protection Act 2018 06-Jun-2022 (transclusion) (← links)
• Document:GBR Directive 2001/20/EC 04-Apr-2001 (transclusion) (← links)
• Document:GBR Directive 90/385/EEC 05-Sep-2007 (transclusion) (← links)
• Document:GBR Directive 93/42/EEC 11-Oct-2007 (transclusion) (← links)
• Document:GBR Directive 98/79/EC 20-Dec-2011 (transclusion) (← links)
• Document:GBR GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL 08-Jul-2020 (transclusion) (← links)
• Document:GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447 (transclusion) (← links)
• Document:GBR Guidance Managing clinical trials during Coronavirus (COVID-19) 16-Nov-.2021 (transclusion) (← links)
• Document:GBR HRA - Ending your project 28-Jan-2025 (transclusion) (← links)
• Document:GBR Guidance - Good clinical practice for clinical trials 16-Oct-2015 (transclusion) (← links)
• Document:GBR IRAS - Integrated Research Application System 28-Jan-2025 (transclusion) (← links)
• Document:GBR Making changes to a research study to manage the impact of COVID-19 12-Oct-2021 (transclusion) (← links)
• Document:GBR MEDDEV 2.7/3 revision 3 May-2015 (transclusion) (← links)
• Document:GBR Medicines and Medical Devices Act 2021 21-Feb-2021 (transclusion) (← links)
• Document:GBR National Health Service Act 2006 02-Dec-2019 (transclusion) (← links)
• Document:GBR NHS: Records Management Code of Practice 07-Aug-2023 (transclusion) (← links)
• Document:GBR NIHR - National Institute for Health and Care Research 28-Jan-2025 (transclusion) (← links)
• Document:GBR The Electronic Identification and Trust Services for Electronic Transactions (Amendment etc.) (EU Exit) Regulations 2019 23-Jan-2019 (transclusion) (← links)
• Document:GBR The Human Medicines Regulations 2012 01-Jan-2025 (transclusion) (← links)
• Document:GBR The Medical Devices Regulations 2002 11-Feb-2021 (transclusion) (← links)
• Document:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 (transclusion) (← links)
• Document:GBR UK GDPR - United Kingdom General Data Protection Regulation 31-Dec-2020 (transclusion) (← links)
• Document:USA 21 CFR Part 11 09-Apr-2025 (transclusion) (← links)
• Document:USA 21 CFR Part 312 09-Apr-2025 (transclusion) (← links)
• Document:USA 21 CFR Part 314 09-Apr-2025 (transclusion) (← links)
• Document:USA 21 CFR Part 320 09-Apr-2025 (transclusion) (← links)
• Document:USA 21 CFR Part 50 09-Apr-2025 (transclusion) (← links)
• Document:USA 21 CFR Part 54 09-Apr-2025 (transclusion) (← links)
• Document:USA 21 CFR Part 56 09-Apr-2025 (transclusion) (← links)
• Document:USA 21 CFR Part 809 06-May-2024 (transclusion) (← links)
• Document:USA 21 CFR Part 812 09-Apr-2025 (transclusion) (← links)
• Document:USA 42 CFR Part 11 09-Apr-2025 (transclusion) (← links)
• Document:USA 45 CFR Part 160 09-Apr-2025 (transclusion) (← links)
• Document:USA 45 CFR Part 46 09-Apr-2025 (transclusion) (← links)
• Document:USA Acceptance of Clinical Data to Support Medical Device Applications and Submissions Frequently Asked Questions - Guidance for Industry and Food and Drug Administration Staff 21-Feb-2018 (transclusion) (← links)
• Document:USA CTCAE - Common Terminology Criteria for Adverse Events v5.0 (2017) (transclusion) (← links)
• Document:USA Expedited Review: Categories of Research that may be Reviewed Through an Expedited Review Procedure 1998 (transclusion) (← links)
• Document:USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023 (transclusion) (← links)
• Document:USA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1): Guidance for Industry March 2018 (transclusion) (← links)
• Document:USA FDA - HUMAN DRUG CGMP NOTES Volume 8, Number 3 (transclusion) (← links)
• Document:USA FDA Guidance for Clinical Investigators, Sponsors, and IRBs Adverse Event Reporting to IRBs — Improving Human Subject Protection Jan-2009 (transclusion) (← links)
• Document:USA FDA Guidance for Industry - Computerized Systems Used in Clinical Investigations May-2007 (transclusion) (← links)
• Document:USA FDA Guidance for Industry - Computerized Systems Used in Clinical Trials 13-Apr-2015 (transclusion) (← links)
• Document:USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020 (transclusion) (← links)
• Document:USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013 (transclusion) (← links)
• Document:USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 (transclusion) (← links)